Overview
Beta-Amyloid (1-17)-Cys is a crucial peptide for research into Alzheimer’s disease and related neurological conditions. This 1 mg peptide is a modified fragment of the beta-amyloid peptide, specifically with cysteine substituted for valine at position 17. The importance of this amino acid modification lies in its potential to enhance stability and reactivity in various laboratory applications. Researchers can utilize this peptide to study the aggregation processes of amyloid-beta, contributing to a better understanding of neurodegenerative diseases.
Key Features
- Modified beta-amyloid peptide for enhanced stability
- Cysteine substitution at position 17
- Ideal for research on Alzheimer’s disease
- Suitable for various experimental applications
- Available in a convenient 1 mg size
Specifications
| Property | Details |
|---|---|
| Peptide Sequence | beta-Amyloid (1-17)-Cys |
| Substitution | Cysteine for Valine at position 17 |
| Size | 1 mg |
FAQ
What is the significance of the cysteine substitution?
The cysteine substitution at position 17 allows for greater stability and increases the potential for specific interactions during experimental procedures.
How can I use Beta-Amyloid (1-17)-Cys in my studies?
You can utilize Beta-Amyloid (1-17)-Cys for assays focused on neuronal health, amyloid aggregation, and related biochemical pathways in Alzheimer’s research.
Where can I find other peptides for my research?
Explore our extensive collection of peptides, including related products like PKG Substrate and Autocamtide-2to support your research needs.
For scientists in need of specific peptide sequences, our catalog includes multiple options tailored for diverse applications. With the ability to purchase Beta-Amyloid (1-17)-Cys easily, you’re just a few clicks away from advancing your research.
Related Products
Browse more in Peptides.




Reviews
There are no reviews yet.